Browsing publications by Dr Peter Donaldson

Newcastle AuthorsTitleYearFull text
Dr Yang-Lin LIU
Dr Helen Reeves
Professor Alastair Burt
Dr Dina Tiniakos
Dr Stuart McPherson
et al.
TM6SF2 rs58542926 Influences Hepatic Fibrosis Progression in Patients with Non-Alcoholic Fatty Liver Disease2014
Professor Heather Cordell
Dr Peter Donaldson
Baseline Predictive Factors of Ursodeoxycholic Acid Response in Primary Biliary Cirrhosis2013
Professor Heather Cordell
Dr Peter Donaldson
Factors Associated with Poor Outcome in Primary Biliary Cirrhosis2013
Professor Heather Cordell
Sam Ducker
Dr Peter Donaldson
Professor David Jones
Dense fine-mapping study identifies new susceptibility loci for primary biliary cirrhosis2012
Professor Heather Cordell
Sam Ducker
Dr Peter Donaldson
Professor David Jones
Dense fine-mapping study identifies novel disease loci and implicates coding and non-coding variation in primary Mary cirrhosis risk2012
Dr Peter Donaldson
Electrostatic modifications of the human leukocyte antigen DR P9 peptide-binding pocket in primary sclerosing cholangitis: Back to the future with human leukocyte antigen DR beta2011
Professor Heather Cordell
Dr Peter Donaldson
Sam Ducker
Professor David Jones
Genome-wide association study identifies 12 new susceptibility loci for primary biliary cirrhosis2011
Professor Chris Day
Dr Peter Donaldson
Professor Ann Daly
Susceptibility to amoxicillin-clavulanate-induced liver injury is influenced by multiple HLA class I and class II alleles2011
Professor Heather Cordell
Dr Peter Donaldson
Professor David Jones
Genome-wide association study identifies more than 10 primary biliary cirrhosis risk loci2010
Dr Peter Donaldson
Professor Ann Daly
Jill Henderson
Professor Chris Day
Human leucocyte antigen class II genotype in susceptibility and resistance to co-amoxiclav-induced liver injury2010
1234567891011